{
     "PMID": "27280380",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170529",
     "LR": "20171226",
     "IS": "1520-4804 (Electronic) 0022-2623 (Linking)",
     "VI": "59",
     "IP": "13",
     "DP": "2016 Jul 14",
     "TI": "Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.",
     "PG": "6265-80",
     "LID": "10.1021/acs.jmedchem.6b00478 [doi]",
     "AB": "We describe the synthesis of gramine derivatives and their pharmacological evaluation as multipotent drugs for the treatment of Alzheimer's disease. An innovative multitarget approach is presented, targeting both voltage-gated Ca(2+) channels, classically studied for neurodegenerative diseases, and Ser/Thr phosphatases, which have been marginally aimed, even despite their key role in protein tau dephosphorylation. Twenty-five compounds were synthesized, and mostly their neuroprotective profile exceeded that offered by the head compound gramine. In general, these compounds reduced the entry of Ca(2+) through VGCC, as measured by Fluo-4/AM and patch clamp techniques, and protected in Ca(2+) overload-induced models of neurotoxicity, like glutamate or veratridine exposures. Furthermore, we hypothesize that these compounds decrease tau hyperphosphorylation based on the maintenance of the Ser/Thr phosphatase activity and their neuroprotection against the damage caused by okadaic acid. Hence, we propose this multitarget approach as a new and promising strategy for the treatment of neurodegenerative diseases.",
     "FAU": [
          "Lajarin-Cuesta, Rocio",
          "Nanclares, Carmen",
          "Arranz-Tagarro, Juan-Alberto",
          "Gonzalez-Lafuente, Laura",
          "Arribas, Raquel L",
          "Araujo de Brito, Monique",
          "Gandia, Luis",
          "de Los Rios, Cristobal"
     ],
     "AU": [
          "Lajarin-Cuesta R",
          "Nanclares C",
          "Arranz-Tagarro JA",
          "Gonzalez-Lafuente L",
          "Arribas RL",
          "Araujo de Brito M",
          "Gandia L",
          "de Los Rios C"
     ],
     "AD": "Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Servicio de Farmacologia Clinica, Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa , C/Diego de Leon, 62, 28006 Madrid, Spain. Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Programa de Pos Graduacao em Ciencias Aplicadas a Produtos Para a Saude, Faculdade de Farmacia, Universidade Federal Fluminense , Niteroi, Rio de Janeiro, Brasil. Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Instituto Teofilo Hernando and Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid , C/Arzobispo Morcillo, 4, 28029 Madrid, Spain. Servicio de Farmacologia Clinica, Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa , C/Diego de Leon, 62, 28006 Madrid, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160624",
     "PL": "United States",
     "TA": "J Med Chem",
     "JT": "Journal of medicinal chemistry",
     "JID": "9716531",
     "RN": [
          "0 (Alkaloids)",
          "0 (Calcium Channels)",
          "EC 3.1.3.16 (Phosphoprotein Phosphatases)",
          "FGQ8A78L14 (gramine)"
     ],
     "SB": "IM",
     "MH": [
          "Alkaloids/chemical synthesis/chemistry/*pharmacology",
          "Animals",
          "Calcium Channels/*metabolism",
          "Cattle",
          "Cell Survival/drug effects",
          "Dose-Response Relationship, Drug",
          "Hippocampus/drug effects/metabolism",
          "Humans",
          "Molecular Structure",
          "Neurodegenerative Diseases/*drug therapy/metabolism",
          "Phosphoprotein Phosphatases/*antagonists & inhibitors/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Structure-Activity Relationship",
          "Tumor Cells, Cultured"
     ],
     "EDAT": "2016/06/10 06:00",
     "MHDA": "2017/05/30 06:00",
     "CRDT": [
          "2016/06/10 06:00"
     ],
     "PHST": [
          "2016/06/10 06:00 [entrez]",
          "2016/06/10 06:00 [pubmed]",
          "2017/05/30 06:00 [medline]"
     ],
     "AID": [
          "10.1021/acs.jmedchem.6b00478 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Med Chem. 2016 Jul 14;59(13):6265-80. doi: 10.1021/acs.jmedchem.6b00478. Epub 2016 Jun 24.",
     "term": "hippocampus"
}